Results

Total Results: 21 records

Showing results for "depression".
Users also searched for: guidelines

  1. srdrplus.ahrq.gov/published_projects?page=32
    June 27, 2021 - 27, 2021 Diagnostic Accuracy of Screening Tests and Treatment of Post-Acute Coronary Syndrome (ACS) Depression … updated on June 27, 2021 Objectives: Objective: To evaluate (1) the diagnostic accuracy of selected depression … in adult patients who have received a criterion-based diagnosis of depression or had clinically important … depressive symptoms using a validated depression scale, and who are within 3 months of an ACS event. … in patients after ACS or that evaluated interventions for treating post-ACS patients identified with depression
  2. srdrplus.ahrq.gov/published_projects?page=6
    July 24, 2023 - Forms Project created on July 13, 2022 Last updated on July 19, 2023 Objectives: Screening for Anxiety Depression … 2021 Last updated on June 21, 2023 Objectives: READ MORE Published on June 20, 2023 Screening for Depression … June 20, 2023 Objectives: Objective: To review the benefits and harms of screening and treatment for depression … with a lower prevalence of depression or clinically important depressive symptomatology after six to … Conclusions: Both direct and indirect evidence support depression screening in primary care settings,
  3. srdrplus.ahrq.gov/published_projects?page=51
    June 23, 2021 - Published on June 23, 2021 Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression … Background: Depressive disorders such as major depressive disorder (MDD), dysthymia, and subsyndromal depression … conclusions about the comparative efficacy and effectiveness for the treatment of dysthymia and subsyndromal depression
  4. srdrplus.ahrq.gov/published_projects?page=31
    October 31, 2022 - Published Projects Search for more Projects Published on June 27, 2021 Definition of Treatment-Resistant Depression … The purpose of this technology assessment is to review the current definitions of treatment-resistant depression
  5. srdrplus.ahrq.gov/published_projects?page=20
    June 27, 2021 - evidence (SOE) for key outcomes: health-related quality of life, patient overall symptom burden, patient depressivesymptom scores, patient and caregiver satisfaction, and advance directive documentation. … care were not more effective than usual care for improving health-related quality of life or patient depressivesymptom scores (SOE: Moderate) and may have little to no effect on increasing patient satisfaction or … support, and caregiver feedback (i.e. discrete adaptations of REACH II), may improve informal caregiver depression
  6. srdrplus.ahrq.gov/published_projects?page=41
    June 27, 2021 - Recently Published Projects Search for more Projects Published on June 27, 2021 Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder - Medication Strategies 4 Citations • 4 Key Questions • 4 Extraction Forms Project created on June 27, 2021 Last updated on June 27, 202…
  7. srdrplus.ahrq.gov/published_projects?page=3
    November 22, 2023 - One fair-quality RCT from Iran demonstrated lower rates of postpartum depression at 6-8 weeks for those … compared with controls (20% [11/55] vs. 50% [27/54], p=0.001), measured by the Edinburgh Postpartum Depression
  8. srdrplus.ahrq.gov/published_projects?page=48
    October 31, 2022 - Second-generation antidepressants decreased depression. … CBT for BED was generally ineffective for reducing weight or depression in this population.
  9. srdrplus.ahrq.gov/published_projects?page=53
    March 03, 2021 - and Drug Administration (FDA) for treatment of schizophrenia, bipolar disorder, and for some drugs, depression … disorder, an existing metaanalysis and 10 trials of risperidone or olanzapine for PTSD, 36 trials for depression
  10. srdrplus.ahrq.gov/published_projects?page=30
    June 27, 2021 - comparator arms enrolling adults with BD of any type with 3 weeks followup for acute mania, 3 months for depression … We excluded acute mania and depression studies with greater than 50 percent attrition. Results. … All other drug comparisons to placebo or active controls for acute mania, depression, and maintenance … For psychosocial interventions, cognitive behavioral training (CBT) was no better for depression or mania
  11. srdrplus.ahrq.gov/published_projects?page=25
    June 27, 2021 - Twenty-eight studies indicated genetic counseling is associated with reduced breast cancer worry, anxiety, and depression … Jews detected more BRCA1/2 mutations than family-history based testing, while measures of anxiety, depression … Genetic counseling reduces breast cancer worry, anxiety, and depression; increases understanding of risk
  12. srdrplus.ahrq.gov/published_projects?page=42
    June 27, 2021 - Recently Published Projects Search for more Projects Published on June 27, 2021 Blood Pressure Targets in CKD 3 Citations • 44 Key Questions • 3 Extraction Forms Project created on June 27, 2021 Last updated on June 27, 2021 Objectives: Background: The optimal blood pressure target in patients with chronic kidney dise…
  13. srdrplus.ahrq.gov/published_projects?page=16
    July 29, 2022 - Recently Published Projects Search for more Projects Published on December 14, 2021 Treatment of Depression
  14. srdrplus.ahrq.gov/published_projects?page=5
    October 12, 2023 - Forms Project created on July 14, 2022 Last updated on July 19, 2023 Objectives: Screening for Anxiety Depression … Forms Project created on July 14, 2022 Last updated on July 19, 2023 Objectives: Screening for Anxiety Depression … Forms Project created on July 13, 2022 Last updated on July 19, 2023 Objectives: Screening for Anxiety Depression
  15. srdrplus.ahrq.gov/published_projects?page=14
    June 27, 2022 - no differences between telehealth IPV services versus comparators for outcomes measuring repeat IPV, depression
  16. srdrplus.ahrq.gov/published_projects?page=26
    June 27, 2021 - risk difference for any adverse event, and 5% absolute risk difference for hypotension, respiratory depression … Opioids cause less dizziness than ketamine (low SOE) but may increase the risk of respiratory depression
  17. srdrplus.ahrq.gov/published_projects?page=27
    June 27, 2021 - Search for more Projects Published on June 27, 2021 Adverse Effects of Pharmacologic Treatments of Major Depression
  18. srdrplus.ahrq.gov/published_projects?page=17
    November 22, 2023 - Back pain, depression, concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs), and fibromyalgia
  19. srdrplus.ahrq.gov/published_projects?page=43
    June 27, 2021 - populations focused primarily on treatment of chronic physical or mental health conditions (e.g., diabetes, depression
  20. srdrplus.ahrq.gov/published_projects?page=8
    May 30, 2023 - primary care providers found that participants scored within the normal range on measures of anxiety and depression

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: